findmyKOL

Stacie Daugherty, MD

Enriched profile

Senior Clinician Investigator, Institute for Health Research, Kaiser Permanente Colorado · Kaiser Permanente Colorado

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Lone Tree, CO · West · United StatesSpecialtyCardiovascular DiseaseFocusSex and Gender in Healthcare+4
Active KOLfindmyKOL type: EliteLatest publication2026Online presenceNone verifiedPayments2021–2021NIH funding2010–2019

Stacie Daugherty is Senior Clinician Investigator, Institute for Health Research, Kaiser Permanente Colorado at Kaiser Permanente Colorado. OpenAlex indexes 145 publications with 5,780 citations (h-index 35); ClinicalTrials.gov lists 2 registered studies with this person as an investigator.

Data verified 23 Oct 2026

Overview

Updated 23 Oct 2026

Stacie Daugherty, MD, is Senior Clinician Investigator, Institute for Health Research, Kaiser Permanente Colorado. The public record shows 145 publications with 5,780 citations (h-index 35), centered on Sex and Gender in Healthcare, Acute Myocardial Infarction Research, Cardiac Arrest and Resuscitation. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 1 companies, 2 NIH-funded awards (2010–2019).

  • Most recent indexed publication: 2026 · Journal of the American Heart Association
  • Top research focus: Sex and Gender in Healthcare
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 1 companies

Generated from the cited public record · current as of 23 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Cardiovascular Diseases1 trialVascular Diseases1 trialHypertension1 trial

Research focus

OpenAlex concept fingerprint
Sex and Gender in HealthcareAcute Myocardial Infarction ResearchCardiac Arrest and ResuscitationPalliative Care and End-of-Life IssuesRacial and Ethnic Identity Research

Works with

trial sponsors and companies reporting payments
Kaiser PermanenteClinical trials1Industry payments—Novo Nordisk IncClinical trials—Industry payments1University of Colorado, DenverClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
145publications

Distinct works indexed by OpenAlex, matched via ORCID; 8 in PubMed.

5,780citations

Total citations across indexed works.

35h-index

Hirsch index (OpenAlex). i10-index 55.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
1companies · 2021–2021

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
2NIH grants · 2010–2019

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 23 Oct 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 23 Oct 2026

1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    89.5%
    Beta blocker36.2%
    Metoprolol Succinate66%Metoprolol Tartrate22%Carvedilol12%
    Part D<11 patients
    Statin18.6%
    Atorvastatin Calcium80%Rosuvastatin Calcium21%
    Part D<11 patients

    + 5 more classes in this area

  • Metabolism & gastrointestinal

    7.7%
    SGLT2 inhibitor7.7%
    Jardiance100%
    Part D<11 patients
  • Nervous system

    2.8%
    Other nervous system drugs2.8%
    Vyndamax100%
    Part D<11 patients
Where care is delivered (Part B), 2021100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 23 Oct 2026

2 NIH research awards on record, funded 2010–2019 per NIH RePORTER. The latest:

Congress activity

Updated 23 Oct 2026

1 congress contribution (2023) across ADA per OpenAlex. The most recent:

Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.

Publications

Updated 23 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 23 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Frederick A. Masoudi34Edward P. Havranek32Irene V. Blair32Pamela N. Peterson23P. Michael Ho21Sarah M. Perman19Thomas M. Maddox18Daniel D. Matlock14Lauren E. Thompson14John A. Spertus13Suma X. Vupputuri13Steven M. Bradley12Rebecca L. Hanratty12Laura J. Helmkamp12Chad M. Danyluck11Mark L. Laudenslager10David J. Magid9Spero M. Manson9Bonnie Siry‐Bove9GREGORY J. DEHMER9John F. Steiner9Philip G. Jones9Shelby K. Shelton8Paul S. Chan8Nicole Martin Bhave8Fengming Tang8John U. Doherty8Jeptha P. Curtis7Joshua Correll7Milind Y. Desai7Christopher E. Knoepke7Khadijah K Breathett7Linda D. Gillam7L. Miriam Dickinson7Larry A. Allen7David E. Winchester7Julie Maertens7Larry S. Dean7John S. Rumsfeld7Ritu Sachdeva6

Background & recognition

Updated 23 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Secondary affiliations

appointments beyond the home institution

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.